As of January 2025 Galectin Therapeutics has a market cap of €75.66 Million. This makes Galectin Therapeutics the world's 9252th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 16th, 2025 the market cap of Galectin Therapeutics was reported to be: